Both the analyses of IL-18 on IBD (Fig. 2) and on eczema/dermatitis (Supplementary Material, Fig. S2) survived leave-one-out analyses (Supplementary Material, Table S5), as the removal of any individual SNP from the analysis had little effect on observed effect estimates. This evidence concerns the gene IL18 and inflammatory bowel disease.